Muser Daniele, Liang Jackson J, Witschey Walter Rt, Pathak Rajeev K, Castro Simon, Magnani Silvia, Zado Erica S, Garcia Fermin C, Desjardins Benoit, Callans David J, Frankel David S, Marchlinski Francis E, Santangeli Pasquale
Cardiovascular Medicine Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Heart Rhythm. 2017 Feb;14(2):166-175. doi: 10.1016/j.hrthm.2016.11.014. Epub 2016 Nov 24.
Left ventricular noncompaction (LVNC) is a primary cardiomyopathy that can present with recurrent ventricular arrhythmias (VAs). Data on the benefit of catheter ablation of VAs in LVNC are lacking.
The purpose of this study was to describe the electrophysiologic features and outcomes of catheter ablation of VAs in LVNC.
The cohort consisted of 9 patients (age 42 ± 15 years) with diagnosis of LVNC based on established criteria and VA (ventricular tachycardia [VT] in 3 and frequent premature ventricular contractions (PVCs) in 6) despite treatment with a mean of 2 ± 1 antiarrhythmic drugs. Ablation sites were identified using a combination of entrainment, activation, late/fractionated potential ablation, and pace-mapping.
A total of 8 patients (89%) had left ventricular (LV) systolic dysfunction (mean ejection fraction 40% ± 13%). Patients who presented with VT had evidence of abnormal electroanatomic substrate involving the mid- to apical segments of the LV, which matched the noncompacted myocardial segments identified by preprocedural magnetic resonance imaging or echocardiography. In patients presenting with frequent PVCs, the site of origin was identified at the papillary muscles (50%) and/or basal septal regions (67%). After median follow-up of 4 years (range 1-11) and a mean of 1.8 ± 1.1 procedures, VAs recurred in 1 patient (11%). Significant improvement in LV function occurred in 4 of 8 cases (50%). No patients died or underwent heart transplantation.
The VA substrate in patients with LVNC and VT typically involves the mid-apical LV segments, whereas focal PVCs often arise from LV basal-septal regions and/or papillary muscles. Catheter ablation is safe and effective in achieving good VA control over long-term follow-up in most patients.
左心室心肌致密化不全(LVNC)是一种原发性心肌病,可表现为反复发作的室性心律失常(VA)。目前缺乏关于LVNC患者行室性心律失常导管消融治疗益处的数据。
本研究旨在描述LVNC患者室性心律失常导管消融的电生理特征及结果。
该队列包括9例患者(年龄42±15岁),根据既定标准诊断为LVNC且存在室性心律失常(3例为室性心动过速[VT],6例为频发室性早搏[PVC]),尽管平均使用了2±1种抗心律失常药物进行治疗。通过拖带、激动标测、晚期/碎裂电位消融和起搏标测相结合的方法确定消融部位。
共有8例患者(89%)存在左心室(LV)收缩功能障碍(平均射血分数40%±13%)。表现为VT的患者有证据显示电解剖基质异常,累及LV的中至心尖段,这与术前磁共振成像或超声心动图确定的心肌致密化不全节段相符。在表现为频发PVC的患者中,起源部位确定为乳头肌(50%)和/或基底间隔区域(67%)。中位随访4年(范围1 - 11年),平均进行1.8±1.1次手术,1例患者(11%)室性心律失常复发。8例中有4例(50%)LV功能有显著改善。无患者死亡或接受心脏移植。
LVNC合并VT患者的室性心律失常基质通常累及LV中至心尖段,而局灶性PVC常起源于LV基底间隔区域和/或乳头肌。在大多数患者的长期随访中,导管消融在实现良好的室性心律失常控制方面安全有效。